Идёт
Фаза III
Россия
acalabrutinib; placebo; Prednisone; Rituximab; Cyclophosphamide; Vincristine; Doxorubicin · Acerta Pharma BV
Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Acalabrutinib in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Subjects ≤75 Years With Previously Untreated Non-GCB DLBCL